Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 70 articles:
HTML format
Text format



Single Articles


    April 2018
  1. CHOI HJ, Joo HS, Won HY, Min KW, et al
    Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  2. VERMA V, Simone CB 2nd, Mishra MV
    Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    February 2018
  3. HEINDL A, Sestak I, Naidoo K, Cuzick J, et al
    Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  4. TROESTER MA, Sun X, Allott EH, Geradts J, et al
    Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  5. BANDOS H, Melnikow J, Rivera DR, Swain SM, et al
    Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  6. RIVERA DR, Ganz PA, Weyrich MS, Bandos H, et al
    Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  7. JAGSI R, Momoh AO, Qi J, Hamill JB, et al
    Impact of Radiotherapy on Complications and Patient-Reported Outcomes After Breast Reconstruction.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    January 2018
  8. BLOK EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, et al
    Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  9. GOLDVASER H, Barnes TA, Seruga B, Cescon DW, et al
    Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  10. JOHNSON SB, Park HS, Gross CP, Yu JB, et al
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    November 2017
  11. MEIER M, Orr N
    Genetic Determinants of Breast Cancer Risk in Childhood Cancer Survivors.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  12. MORTON LM, Sampson JN, Armstrong GT, Chen TH, et al
    Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  13. DESHMUKH AA, Shirvani SM, Lal L, Swint JM, et al
    Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  14. SCHWARZ LJ, Hutchinson KE, Rexer BN, Estrada MV, et al
    An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    October 2017
  15. LAMBERTINI M, Kroman N, Ameye L, Cordoba O, et al
    Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.
    J Natl Cancer Inst. 2017 Oct 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. VISSCHER DW, Frank RD, Carter JM, Vierkant RA, et al
    Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available



  17. Restarting Adjuvant Hormone Therapy Improves Breast Cancer Outcomes.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  18. HE W, Smedby KE, Fang F, Olsson H, et al
    Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  19. HERMELINK K, Buhner M, Sckopke P, Neufeld F, et al
    Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  20. ROBSON ME, Reiner AS, Brooks JD, Concannon PJ, et al
    Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    September 2017
  21. BYRNE C, Ursin G, Martin CF, Peck JD, et al
    Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    August 2017
  22. POLLACK CE, Soulos PR, Herrin J, Xu X, et al
    The Impact of Social Contagion on Physician Adoption of Advanced Imaging Tests in Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  23. SCHMIDT MK, van den Broek AJ, Tollenaar RA, Smit VT, et al
    Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  24. GINGRAS I, Holmes E, De Azambuja E, Nguyen DH, et al
    Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    July 2017
  25. SHAFAEE MN, Ellis MJ
    Breast Cancer Patient-Derived Xenografts: Pros, Cons, and Next Steps.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  26. WU X, Ye Y, Barcenas CH, Chow WH, et al
    Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  27. ROJAS PA, May M, Sequeira GR, Elia A, et al
    Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  28. GOETZ MP, Kalari KR, Suman VJ, Moyer AM, et al
    Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  29. KUCHENBAECKER KB, McGuffog L, Barrowdale D, Lee A, et al
    Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    June 2017
  30. SAMANTA SK, Sehrawat A, Kim SH, Hahm ER, et al
    Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  31. DAVE B, Gonzalez DD, Liu ZB, Li X, et al
    Role of RPL39 in Metaplastic Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available



  32. Higher consumption of grilled, barbecued, and smoked meat linked to increased mortality risk among breast cancer survivors.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    May 2017
  33. KERLIKOWSKE K, Gard CC, Tice JA, Ziv E, et al
    Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  34. WALTER JR, Xu S, Woodruff TK
    A Call for Fertility Preservation Coverage for Breast Cancer Patients: The Cost of Consistency.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    April 2017
  35. NOLAN E, Vaillant F, Visvader JE, Lindeman GJ, et al
    RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    J Natl Cancer Inst. 2017 Apr 4. doi: 10.1093.
    PubMed     Text format    


  36. SCHERNHAMMER ES
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  37. HANSEN J
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  38. ERREN TC, Morfeld P, Gross JV
    RE: Night Shiftwork and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  39. STEVENS RG
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  40. GARRIDO-CASTRO AC, Winer EP
    Genomic Profiling in Node-Positive ER-Positive Early Breast Cancer: Can Tumor Biology Guide Locoregional Therapy?
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    March 2017
  41. MA R, Karthik GM, Lovrot J, Haglund F, et al
    Estrogen Receptor beta as a Therapeutic Target in Breast Cancer Stem Cells.
    J Natl Cancer Inst. 2017;109:1-14.
    PubMed     Text format     Abstract available


    February 2017
  42. ERIKSEN KT, McElroy JA, Harrington JM, Levine KE, et al
    Urinary Cadmium and Breast Cancer: A Prospective Danish Cohort Study.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  43. GREENLEE H, Hershman DL, Shi Z, Kwan ML, et al
    BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  44. BANEGAS MP, John EM, Slattery ML, Gomez SL, et al
    Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  45. SINDZINSKI A
    Risk of Heart Disease in Breast Cancer Patients Receiving Estrogen-Deprivation Therapy.
    J Natl Cancer Inst. 2017;109:2-3.
    PubMed     Text format    


  46. GREENLEE H, Hershman DL, Shi Z, Kwan ML, et al
    BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.
    J Natl Cancer Inst. 2017;109:1-8.
    PubMed     Text format     Abstract available


  47. ERIKSEN KT, McElroy JA, Harrington JM, Levine KE, et al
    Urinary Cadmium and Breast Cancer: A Prospective Danish Cohort Study.
    J Natl Cancer Inst. 2017;109:1-7.
    PubMed     Text format     Abstract available


  48. SINDZINSKI A
    Risk of Heart Disease in Breast Cancer Patients Receiving Estrogen-Deprivation Therapy.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    January 2017
  49. PARADA H JR, Steck SE, Bradshaw PT, Engel LS, et al
    Grilled, Barbecued, and Smoked Meat Intake and Survival Following Breast Cancer.
    J Natl Cancer Inst. 2017 Jan 4. pii: djw299. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. KOTSOPOULOS J, Huzarski T, Gronwald J, Singer CF, et al
    Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  51. HILAKIVI-CLARKE L, Warri A, Bouker KB, Zhang X, et al
    Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  52. SMITH BD, Jiang J, Shih YC, Giordano SH, et al
    Cost and Complications of Local Therapies for Early-Stage Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  53. PARKES EE, Walker SM, Taggart LE, McCabe N, et al
    Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  54. BENSE RD, Sotiriou C, Piccart-Gebhart MJ, Haanen JB, et al
    Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  55. MAMOUNAS EP, Liu Q, Paik S, Baehner FL, et al
    21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  56. HAAS JS
    The Complexity of Achieving the Promise of Precision Breast Cancer Screening.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  57. SHIEH Y, Eklund M, Madlensky L, Sawyer SD, et al
    Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available



  58. Different Breast Cancer Treatment Options Vary Widely in their Cost-Effectiveness.
    J Natl Cancer Inst. 2017;109:1-2.
    PubMed     Text format    


    December 2016
  59. TRAVIS RC, Balkwill A, Fensom GK, Appleby PN, et al
    Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available



  60. Night Shift Work and Breast Cancer Risk.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    November 2016
  61. TER BRUGGE P, Kristel P, van der Burg E, Boon U, et al
    Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  62. VISVANATHAN K, Yager JD
    Ethnic Variations in Estrogen and Its Metabolites: Sufficient to Explain Differences in Breast Cancer Incidence Rates?
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    October 2016
  63. MOORE SC, Matthews CE, Ou Shu X, Yu K, et al
    Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  64. VISVANATHAN K, Yager JD
    Ethnic Variations in Estrogen and Its Metabolites: Sufficient to Explain Differences in Breast Cancer Incidence Rates?
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    August 2016
  65. MARTIN LJ, Huszti E, Connelly PW, Greenberg CV, et al
    RE: Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  66. TOOMEY S, Eustace AJ, Pritzker LB, Pritzker KP, et al
    RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  67. SCHMIDT C
    Mammaprint Reveals Who Can Skip Chemotherapy for Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    June 2016
  68. FILLON M
    Continuing To Smoke After Breast Cancer Diagnosis Lowers Survival Rate.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    April 2016
  69. AZVOLINSKY A
    Unraveling How Obesity Fuels Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  70. JENKS S
    Digital Imaging of the Breast: Is a Synthetic View Better?
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: